Synapse - Hematologic Malignancies, Division of

Search Within

Hematologic Malignancies, Division of

Results (13379)

DNA immunization against melanoma antigens enhances tumor immunity in mice following sub-lethal irradiation and immune reconstitution

Meeting Abstract

Diab, A.; Hubbard, V. M.; Cohen, A.; Huggins, D.; Kochman, A.; Guevara, J. A; Engelhorn, M.; Wolchok, J. D.; Van Den Brink, M.; Houghton, A. N.; more...
Blood (2004)

Fulltext@MSK | Save

Phase II evaluation of the tyrosine kinase inhibitor MLN518 in patients with acute myeloid leukemia (AML) bearing a FLT3 internal tandem duplication (ITD) mutation

Meeting Abstract

De Angelo, D. J.; Stone, R. M.; Heaney, M. L.; Nimer, S. D.; Paquette, R.; Bruner-Klisovic, R.; Caligiuri, M. A.; Cooper, M. R.; Le-Cerf, J. M.; Iyer, G.
Blood (2004)

Fulltext@MSK | Save

Serious complications following unrelated donor marrow collection: Experiences of the National Marrow Donor Program (R)

Meeting Abstract

Confer, D. L.; Leitman, S. F.; Papadopoulos, E. B.; Price, T. H.; Stroncek, D. F.; Robinett, P.; Braem, B.; Gandham, S.
Biology of Blood and Marrow Transplantation (2004)

Fulltext@MSK | Save

Risk-adapted intravenous melphalan followed by adjuvant dexamethasone (D) and thalidomide (T) for newly diagnosed patients with systemic AL amyloidosis (AL): Interim results of a phase II study

Meeting Abstract

Cohen, A. D.; Zhou, P.; Reich, L.; Quinn, A.; Fircanis, S.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Filippa, D. A.; Fleisher, M.; more...
Blood (2004)

Fulltext@MSK | Save

Clinical outcome correlations of genomic gains and losses in diffuse large B-cell lymphoma by array-CGH

Meeting Abstract

Chen, W. Y.; Olshen, A.; Chaganti, S.; Halaas, J.; Zelenetz, A. D.; Feldstein, J.; Houldsworth, J.; Chaganti, R. S. K.
Blood (2004)

Fulltext@MSK | Save

Position and copy number dependence of the central polypurine tract (cPPT) function in simple and complex lentiviral vectors

Meeting Abstract

Chang, A. H.; Lisowski, L.; Stephan, M.; Riviere, I.; Sadelain, M.
Molecular Therapy (2004)

Fulltext@MSK | Save

A phase II trial of a non-myeloablative regimen combining in vivo T cell depletion with an anti-CD52 monoclonal antibody (alemtuzumab), and chemotherapy with fludarabine and melphalan prior to a related or unrelated hematopoietic stem cell transplantation

Meeting Abstract

Castro-Malaspina, H.; Papadopoulos, E.; Jakubowski, A.; Perales, M. A.; Young, J.; Hsu, K.; Boulad, F.; Prasad, V.; Small, T.; Kernan, N.; more...
Biology of Blood and Marrow Transplantation (2004)

Fulltext@MSK | Save

Analysis of the genomic stability of herpes simplex virus thymidine kinase variants in retrovirally transduced lymphocytes

Meeting Abstract

Capacio, V. L.; Fan, Y.; Stefanski, J.; Chang, A. H.; Sadelain, M.; Riviere, I.
Molecular Therapy (2004)

Fulltext@MSK | Save

A phase II trial of busulfan, melphalan, and fludarabine followed by allogeneic T-cell depleted hematopoietic stem cell transplants from HLA-identical, or HLA-non identical related or unrelated donors for the treatment of advanced hematopoietic malignancies

Meeting Abstract

Boulad, F.; Jakubowski, A.; Castro-Malaspina, H.; Hsu, K. C.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M. A.; Prockop, S. E.; Small, T. N.; van den Brink, M. R. M.; more...
Blood (2004)

Fulltext@MSK | Save

Altered bone and mineral metabolism in patients treated with imatinb

Meeting Abstract

Berman, E.; Nicolaides, M.; Sauter, N.; Chanel, S.; Wilson, B.; Fleisher, M.
Blood (2004)

Fulltext@MSK | Save